Development and assessment of a modified Pediatric Crohn Disease Activity Index

Steven T Leach1, Lily Nahidi, Samantha Tilakaratne

  • 1School of Women's and Children's Health, University of New South Wales, Randwick, Sydney, Australia.

Insights

A modified Pediatric Crohn Disease Activity Index (PCDAI) using lab markers and C-reactive protein offers a reliable alternative for assessing pediatric Crohn disease activity in research settings.

Area of Science:

  • Pediatric gastroenterology
  • Inflammatory bowel disease research
  • Biomarker development

Background:

  • The Pediatric Crohn Disease Activity Index (PCDAI) is a standard tool for measuring Crohn disease activity in children.
  • Subjective and anthropometric elements of the PCDAI can limit its research application.
  • A need exists for a more objective and reproducible disease activity index in pediatric research.

Purpose of the Study:

  • To develop and validate a modified PCDAI (Mod PCDAI) for pediatric Crohn disease research.
  • To assess the Mod PCDAI's correlation with existing disease activity measures.
  • To establish the Mod PCDAI as a viable alternative to the standard PCDAI.

Main Methods:

  • The modified PCDAI (Mod PCDAI) was developed using laboratory measures from the original PCDAI plus C-reactive protein.
  • The Mod PCDAI was evaluated for its correlation with the standard PCDAI.
  • Correlation with physician global assessment and fecal calprotectin was also assessed.

Main Results:

  • The Mod PCDAI demonstrated a significant correlation with the established PCDAI.
  • The Mod PCDAI also showed good correlation with physician global assessment.
  • Correlation with fecal calprotectin further supports the Mod PCDAI's validity.

Conclusions:

  • The modified PCDAI (Mod PCDAI) provides a reliable measure of disease activity in pediatric Crohn disease.
  • The Mod PCDAI may serve as a practical alternative to the PCDAI in research settings.
  • This modified index offers improved objectivity for disease activity assessment.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...